β-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease

被引:0
|
作者
Shreesh Ojha
Hayate Javed
Sheikh Azimullah
M. Emdadul Haque
机构
[1] United Arab Emirates University,Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences
[2] United Arab Emirates University,Department of Biochemistry, College of Medicine and Health Sciences
来源
关键词
β-Caryophyllene; Neurodegeneration; Neurotoxicity; Parkinson disease; Rotenone;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson disease (PD) is a neurodegenerative disease characterized by progressive dopaminergic neurodegeneration in the substantia nigra pars compacta (SNc) area. The present study was undertaken to evaluate the neuroprotective effect of β-caryophyllene (BCP) against rotenone-induced oxidative stress and neuroinflammation in a rat model of PD. In the present study, BCP was administered once daily for 4 weeks at a dose of 50 mg/kg body weight prior to a rotenone (2.5 mg/kg body weight) challenge to mimic the progressive neurodegenerative nature of PD. Rotenone administration results in oxidative stress as evidenced by decreased activities of superoxide dismutase, catalase, and depletion of glutathione with a concomitant rise in lipid peroxidation product, malondialdehyde. Rotenone also significantly increased pro-inflammatory cytokines in the midbrain region and elevated the inflammatory mediators such as cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in the striatum. Further, immunohistochemical analysis revealed loss of dopaminergic neurons in the SNc area and enhanced expression of ionized calcium-binding adaptor molecule-1 (Iba-1) and glial fibrillary acidic protein (GFAP), indicators of microglia activation, and astrocyte hypertrophy, respectively, as an index of inflammation. However, treatment with BCP rescued dopaminergic neurons and decreased microglia and astrocyte activation evidenced by reduced Iba-1 and GFAP expression. BCP in addition to attenuation of pro-inflammatory cytokines and inflammatory mediators such as COX-2 and iNOS, also restored antioxidant enzymes and inhibited lipid peroxidation as well as glutathione depletion. The findings demonstrate that BCP provides neuroprotection against rotenone-induced PD and the neuroprotective effects can be ascribed to its potent antioxidant and anti-inflammatory activities.
引用
收藏
页码:59 / 70
页数:11
相关论文
共 50 条
  • [31] The implication of oxidative stress in a rat model of Parkinson's disease
    Ciobica, A.
    Hritcu, L.
    Artenie, V.
    Padurariu, M.
    JOURNAL OF NEUROCHEMISTRY, 2009, 109 : 297 - 297
  • [32] CNI-1493 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in the Acute MPTP Mouse Model of Parkinson's Disease
    Noelker, Carmen
    Stuckenholz, Vanessa
    Reese, Jens-Peter
    Alvarez-Fischer, Daniel
    Sankowski, Roman
    Rausch, Tanja
    Oertel, Wolfgang H.
    Hartmann, Andreas
    van Patten, Sonya
    Al-Abed, Yousef
    Bacher, Michael
    NEURODEGENERATIVE DISEASES, 2013, 12 (02) : 103 - 110
  • [33] Characterization of the lipopolysaccharide induced Model of Parkinson's disease: Role of oxidative stress and neuroinflammation
    Sharma, Neha
    Nehru, Bimla
    NEUROCHEMISTRY INTERNATIONAL, 2015, 87 : 92 - 105
  • [34] Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson's disease
    Zarbakhsh, Sam
    Safari, Manouchehr
    Aldaghi, Mohammad Reza
    Sameni, Hamid Reza
    Ghahari, Laya
    Lagmouj, Younes Khaleghi
    Jaberi, Khojasteh Rahimi
    Parsaie, Houman
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (07) : 722 - 728
  • [35] Influence of simvastatin on dopaminergic neurons of lipopolysaccharide—induced rat model of Parkinson's disease
    Tan Wang
    Xue-Bin Cao
    Xiao-Wu Chen
    Pei-Pei Huang
    Tian Zhang
    Zhi-Bin Chen
    Bei-Sha Tang
    Asian Pacific Journal of Tropical Medicine, 2015, (01) : 64 - 67
  • [36] Lesion of mesencephalic dopaminergic neurons: a rat model of hypodopaminergic behavior of Parkinson's disease
    Drui, G.
    Carnicella, S.
    Favier, M.
    Carcenac, C.
    Krack, P.
    Savasta, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 32 - 33
  • [37] Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson's Disease
    Chung, Young C.
    Kim, Sang R.
    Jin, Byung K.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (02): : 1230 - 1237
  • [38] CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease
    Wang, Yuejun
    Li, Li
    Wu, Yuting
    Zhang, Shouping
    Ju, Qianqian
    Yang, Yinuo
    Jin, Yan
    Shi, Hui
    Sun, Cheng
    PHARMACOLOGICAL RESEARCH, 2022, 177
  • [39] Pramipexole protects dopaminergic neurons against various forms of oxidative stress relevant for Parkinson's disease
    Gille, G
    Xu, G
    Doreen, B
    Yongjian, M
    Wolf-Dieter, R
    Heinz, R
    MOVEMENT DISORDERS, 2004, 19 : S33 - S33
  • [40] Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer’s disease rat model
    Manickam Rajkumar
    Soundarapandian Kannan
    Ramasundaram Thangaraj
    Inflammopharmacology, 2023, 31 (5) : 2751 - 2771